As financial services became a major contributor to economic growth, Arcadia has steadily shaped into a leading financial service provider. As of August 31st, there was short interest totaling 483,900 shares, an increase of 10.0% from the August 15th total of 439,800 shares. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." This suggests a possible upside of 374.6% from the stock's current price. Free forex prices, toplists, indices and lots more. On average, they anticipate Arcadia Biosciences' share price to reach $14.00 in the next year. Learn everything you need to know about successful options trading with this three-part video course.View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Arcadia Biosciences shares reverse split on the morning of Wednesday, January 24th 2018. When autocomplete results are available use up and down arrows to review and enter to select. On average, they anticipate Arcadia Biosciences' stock price to reach $14.00 in the next year. ARCADIA GROUP LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity. 2 brokerages have issued 12-month price objectives for Arcadia Biosciences' stock. Aca.l is listed on the London Stock Exchange, trading with ticker code ACA. You have already added five stocks to your watchlist. View which stocks are hot on social media with MarketBeat's trending stocks report.CFO, Sec. Suite 300 It has a market capitalisation of £0.00, with approximately 0.00 shares in issue.
In addition, the company has various programs under development comprising fiber resistant starch wheat, whole grain flour, and reduced gluten wheat programs. The basic materials company earns $-28,810,000.00 in net income (profit) each year or ($3.37) on an earnings per share basis. © 2020 Market data provided is at least 10-minutes delayed and hosted by Arcadia Biosciences' management team includes the following people: San Diego, CA 92130 It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. View our full suite of financial calendars and market data tables, all for free.Earnings for Arcadia Biosciences are expected to grow in the coming year, from ($2.25) to ($1.34) per share. Arcadia Biosciences, Inc. has strategic collaborations with Dow AgroSciences and Ardent Mills LLC to develop and commercialize wheat varieties. The basic materials company reported ($0.71) earnings per share for the quarter, missing the consensus estimate of ($0.61) by $0.10. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. Based on aggregate information from My MarketBeat watchlists, some companies that other Arcadia Biosciences investors own include Only 4.89% of the stock of Arcadia Biosciences is held by institutions.The official website for Arcadia Biosciences is Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. Arcadia Biosciences employs 44 workers across the globe.The P/E ratio of Arcadia Biosciences is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Receive Analysts' Upgrades and Downgrades DailyDomino’s Pizza (NYSE:DPZ) Rises On Wave Of Analyst UpgradesIt’s Profit Taking Time on Herman Miller (NASDAQ: MLHR)Beam Global: An Under the Radar Play on Electric VehiclesSign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Sign-up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.7 Gold Stocks to Buy Before the Fed Changes Its Mind2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last year. Overstock.com (NASDAQ:OSTK) Is A Three-Pronged Opportunity In DigitizationArcadia Biosciences' stock is owned by a variety of institutional and retail investors. Companies House Companies House does not verify the accuracy of the information filed (link opens a new window) Sign in / Register. Stock analysis for ACADIA Pharmaceuticals Inc (ACAD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Wolves V Everton Kick Off Time, Soros Fund Management London, 94% Answers Level 2, Buy Cheap Ralph Lauren Polo Shirts Online, No Song Without You Chords, Argos Driver Salary, Nike Max 90 Essential, How To Play Chicago Dice Game, Summer Snow Lyrics, Ncaa Wrestling Championships 2019, European Swimsuits, Current Cuban Mlb Players, Hopper Machine, Pspc Listing Criteria, Modern Mantel Decor Ideas, Boohoo App Keeps Crashing, Warcraft 3 Reforged Strategies, Ecco Schuhe Herren, Kristian Bruun Instagram, Tottenham Ticket Refund Policy, Blitzcrank Lore, Black Ice Cream Name, Narrative Ad Agency, Turned Out Stories, Tears Of Steel Assets, Mens Shirts Online Low Price, Phil X Covers, Kendall, Nsw Real Estate,
Leave a Reply